Purchase of Shares by Directors
12 April 2022, 07:00 UTC By inhc
12 April 2022, 07:00 UTC By inhc
Induction Healthcare Group PLC
(“Induction”, the “Company”, or the “Group”)
Purchase of Shares by Directors
| Name | Position | Number of Ordinary Shares Purchased
|
Price per Ordinary Share | Resultant Shareholding | Percentage of Issued Share Capital |
| James Balmain
|
Chief Executive Officer
|
7,300 | 54.0987p | 706,573 | 0.77% |
| Guy Mitchell
|
Chief Financial Officer
|
9,200 | 54.0987p | 9,200 | 0.01% |
| Hugo Stephenson*
|
Group Executive Director
|
100,000 | 54.0987p | 2,226,273 | 2.42% |
| Leslie-Ann Reed
|
Non-Executive Director
|
57,100 | 52.5p | 57,100 | 0.06% |
| Andy Williams
|
Non-Executive Director | 190,989 | 52.5p | 610,484 | 0.66% |
* Dr Stephenson’s shareholding shown above excludes the 7,152,600 ordinary shares which are held by Blue Muse Investments Pty Ltd, as trustee of The Blue Muse Trust (a trust which is controlled by Hugo Stephenson’s mother and of which close relatives including his children and friends of Hugo Stephenson are beneficiaries).
ENQUIRIES
| Induction
James Balmain, Chief Executive Officer Guy Mitchell, Chief Financial Officer |
Via Walbrook PR Ltd: induction@walbrookpr.com |
| Singer Capital Markets (Nominated Adviser and Broker) | +44 (0)20 7496 3000 |
| Philip Davies / Kailey Aliyar | |
| Walbrook PR Ltd | induction@walbrookpr.com |
| Paul McManus / Alice Woodings | Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 |
About Induction – www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face – enabling a more flexible, efficient and positive experience for the communities they serve. Purpose built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
CLICK HERE FOR FULL ‘PURCHASE OF SHARES BY DIRECTORS’ SUBMISSION